Sixty seconds on . . . prostate cancer screening

Uh oh, there’s that “S” word again . . .

Screening is often a controversial topic within medicine, and a new £5m (€5.6m; $6.3m) trial offering magnetic resonance imaging (MRI) scans to test asymptomatic men for prostate cancer will have raised eyebrows this week after being hyped in the national press. The trial, starting in August, is funded by the Medical Research Council and Cancer Research UK. It will invite 1000 men aged between 55 and 75 years to …